Assessing harm reduction services for drug users

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the effectiveness of an integrated harm reduction intervention (IHRI) compared to standard harm reduction services in improving service utilization among Black and Latinx individuals who use drugs. Participants must be at least 18 years old and have misused opioids or other substances in the past 30 days. The study aims to provide insights into how tailored interventions can better serve marginalized communities affected by substance abuse. The research will be conducted across multiple locations, including NYU Langone Health and Yale University.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* at least 18 years of age
* self-identified as misusing opioids +/- other substances (stimulants) in the past 30 days, confirmed by interview using DSM-5 criteria
* English or Spanish speaking
* able to provide informed consent.

Exclusion Criteria:

* inability to provide informed consent or participate in the study procedures as proposed in the consent
* active suicidal or homicidal ideation or an unstable psychotic disorder (schizophrenia, schizoaffective disorder) or mood disorder (bipolar disorder, severe major depressive disorder)
* an unwillingness to be randomized.
* are prisoners

Where it's running

• Yale University
  New Haven, Connecticut, United States Recruiting
• Nathan Kline Institute
  Orangeburg, New York, United States Recruiting
• NYU Langone Health
  New York, New York, United States Not yet recruiting

Study contacts

• Principal investigator: Ayana Jordan, MD, PhD — NYU Langone Health
• Study coordinator: Ayana Jordan, MD, PhD
• Email: Ayana.Jordan@nyulangone.org
• Phone: (203) 787-8032

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• How people disclose suicidal thoughts and get support in rural eastern Uganda

  This study tests how disclosure of suicidal thoughts or severe distress affects social support or harm, and who should be involved in future help.

  Recruiting Yale University · Mpunde, Buyende District · NCT07730307

• Hybrid DBT for Veterans to Further Reduce PTSD and Emotion Regulation Problems

  This study tests a hybrid dialectical behavior therapy program for veterans with PTSD and emotion regulation issues to see if it helps reduce symptoms and improve daily functioning.

  Recruiting Arkin · Amstelveen, North Holland · NCT07652645

• HB-1 for PTSD: testing safety and efficacy vs placebo in adults 18-65

  This study tests whether HB-1 helps reduce PTSD symptoms in adults aged 18–65 compared with a placebo.

  Recruiting at 16 sites Phase 2 HB BioTech, LLC · Deakin, Australian Capital Territory and 15 other locations · NCT07499440

• Project REACH: Telehealth at syringe service programs to help people who use drugs access HIV-related care

  A telehealth program at syringe service sites will try to connect adults who use drugs with HIV-related services to see if it is feasible and acceptable and may help them get care.

  Recruiting University of Minnesota · Minneapolis, Minnesota · NCT07433712

• Testing the French PHQ-4 and PC-PTSD-5 short mental health screens

  This project will test whether the French PHQ-4 and PC‑PTSD‑5 questionnaires work well to quickly screen for anxiety/depression and PTSD in French-speaking adults seen in hospital or outpatient care.

  Recruiting Assistance Publique - Hôpitaux de Paris · Bobigny · NCT07396623

• Brain imaging to predict teens' response to cannabis treatment

  This project will test whether teens' brain activity during a learning task can predict how well 14–17-year-olds do in a 10-week virtual reward program to reduce cannabis use.

  Recruiting Indiana University · Indianapolis, Indiana · NCT07340554

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.